Securities code: Chongqing Lummy Pharmaceutical Co.Ltd(300006) securities abbreviation: Chongqing Lummy Pharmaceutical Co.Ltd(300006) Announcement No.: 2022007
Chongqing Lummy Pharmaceutical Co.Ltd(300006)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as “the company”) deliberated and approved the proposal on participating in the investment and establishment of Chongqing bilingxing medical intellectual property fund partnership (limited partnership) at the 14th meeting of the 5th board of directors and the 11th meeting of the 5th board of supervisors held on March 29, 2021, and agreed to sign the partnership agreement with Hangzhou bilingxing innovation investment management partnership (limited partnership), Invest and establish Chongqing bilingxing medical intellectual property fund partnership (limited partnership) (finally approved by the industry and commerce as “Chongqing bilingxing private equity investment fund partnership (limited partnership)”) (hereinafter referred to as “partnership”). The partnership has completed the industrial and commercial registration procedures in December 2021 and obtained the business license issued by Chongqing Yuzhong District market supervision and Administration Bureau. For details, please refer to cninfo.com on March 31, 2021 and December 29, 2021（ http://www.cn.info.com.cn. ）Announcement on participating in the investment and establishment of Chongqing bilingxing medical intellectual property fund partnership (limited partnership) (Announcement No.: 2021036) and announcement on completing the industrial and commercial registration of participating in the investment and establishment of partnership (Announcement No.: 2021087).
According to the requirements of laws and regulations such as the securities investment fund law and the Interim Measures for the supervision and administration of private investment funds, the partnership recently completed the filing procedures in the China Securities Investment Fund Industry Association and obtained the private investment fund Filing Certificate. The specific contents are as follows:
Fund Name: Chongqing bilingxing private equity investment fund partnership (limited partnership)
Filing Code: stw366
Name of manager: Hangzhou bilingxing innovative investment management partnership (limited partnership)
Name of custodian: China Merchants Bank Co.Ltd(600036)
Filing date: March 22, 2022
It is hereby announced.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) board of directors March 23, 2022
